AXSM logo

Axsome Therapeutics (AXSM) Cash From Investing

Annual CFI

-$582.00 K
+$53.12 M+98.92%

December 31, 2023

Summary

Performance

1-Year Change

+98.92%

3-Year Change

-1167.97%

5-Year Change

-1679.82%

15-Year Change

-5778.79%

AXSM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.51%
AXSM annual cash flow from investing activities is higher than 47.51% of companies in Healthcare sector

High & Low

All-time High

-$9900.00

3-Year Low

-$53.70 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
AXSM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 18, 2025
AXSM next annual earnings announcement is scheduled for Feb 18, 2025

OtherAXSMcash flowmetrics:

Annual CFF

$331.01 M
AXSM annual cash flow from financing activities is $331.01 million

Annual CFO

-$145.08 M
AXSM annual cash flow from operations is -$145.08 million

Annual FCF

-$145.66 M
AXSM annual free cash flow is -$145.66 million

Annual CAPEX

$582.00 K
AXSM annual capital expenditures is $582.00 thousand

Quarterly CFI

-$90.00 K
-$38.00 K-73.08%

September 30, 2024

Summary

Performance

3-Month Change

-73.08%

1-Year Change

-1185.71%

3-Year Change

+65.21%

5-Year Change

-2712.5%

AXSM Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.55%
AXSM quarterly cash flow from investing activities is higher than 43.55% of companies in Healthcare sector

High & Low

All-time High

$0.00
AXSM quarterly cash flow from investing activities is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$53.24 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AXSM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 18, 2025
AXSM next earnings announcement is scheduled for Feb 18, 2025

OtherAXSMcash flowmetrics:

Quarterly CFF

$30.41 M
AXSM quarterly cash flow from financing activities is $30.41 million

Quarterly CFO

-$18.63 M
AXSM quarterly cash flow from operations is -$18.63 million

Quarterly FCF

-$18.72 M
AXSM quarterly free cash flow is -$18.72 million

Quarterly CAPEX

$90.00 K
AXSM quarterly capital expenditures is $90.00 thousand

TTM CFI

-$247.00 K
+$281.00 K+53.22%

September 30, 2024

Summary

Performance

3-Month Change

+53.22%

1-Year Change

+57.56%

3-Year Change

+24.67%

5-Year Change

-1424.69%

AXSM TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.06%
AXSM TTM cash flow from investing activities is higher than 52.06% of companies in Healthcare sector

High & Low

All-time High

-$9900.00

3-Year Low

-$53.71 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AXSM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 18, 2025
AXSM next earnings announcement is scheduled for Feb 18, 2025

OtherAXSMcash flowmetrics:

TTM CFF

$43.59 M
AXSM TTM cash flow from financing activities is $43.59 million

TTM CFO

-$132.57 M
AXSM TTM cash flow from operations is -$132.57 million

TTM FCF

-$132.82 M
AXSM TTM free cash flow is -$132.82 million

TTM CAPEX

$247.00 K
AXSM TTM capital expenditures is $247.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AXSM Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+98.9%-1185.7%+57.6%
3 y3 years-1168.0%+65.2%+24.7%
5 y5 years-1679.8%-2712.5%-1424.7%

AXSM Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-89.0%+98.9%<-9999.0%+99.8%at high+99.5%
5 y5-year-3514.9%+98.9%<-9999.0%+99.8%-1503.9%+99.5%
alltimeall time-5778.8%+98.9%<-9999.0%+99.8%-2394.9%+99.5%

Axsome Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$90.00 K(+73.1%)
-$247.00 K(-53.2%)
Jun 2024
-
-$52.00 K(-46.9%)
-$528.00 K(-13.3%)
Mar 2024
-
-$98.00 K(+1300.0%)
-$609.00 K(+4.6%)
Dec 2023
-$582.00 K(-98.9%)
-$7000.00(-98.1%)
-$582.00 K(-23.0%)
Sep 2023
-
-$371.00 K(+178.9%)
-$756.00 K(+67.6%)
Jun 2023
-
-$133.00 K(+87.3%)
-$451.00 K(-99.2%)
Mar 2023
-
-$71.00 K(-60.8%)
-$53.56 M(-0.3%)
Dec 2022
-$53.70 M(>+9900.0%)
-$181.00 K(+174.2%)
-$53.70 M(+0.3%)
Sep 2022
-
-$66.00 K(-99.9%)
-$53.52 M(-0.4%)
Jun 2022
-
-$53.24 M(>+9900.0%)
-$53.71 M(>+9900.0%)
Mar 2022
-
-$214.00 K(>+9900.0%)
-$492.10 K(+59.7%)
Dec 2021
-$308.00 K(+571.0%)
-$500.00(-99.8%)
-$308.10 K(-6.0%)
Sep 2021
-
-$258.70 K(+1268.8%)
-$327.90 K(+290.4%)
Jun 2021
-
-$18.90 K(-37.0%)
-$84.00 K(+26.3%)
Mar 2021
-
-$30.00 K(+47.8%)
-$66.50 K(+45.2%)
Dec 2020
-$45.90 K(+185.1%)
-$20.30 K(+37.2%)
-$45.80 K(+69.6%)
Sep 2020
-
-$14.80 K(+957.1%)
-$27.00 K(+75.3%)
Jun 2020
-
-$1400.00(-84.9%)
-$15.40 K(-39.6%)
Mar 2020
-
-$9300.00(+520.0%)
-$25.50 K(+57.4%)
DateAnnualQuarterlyTTM
Dec 2019
-$16.10 K(-50.8%)
-$1500.00(-53.1%)
-$16.20 K(+10.2%)
Sep 2019
-
-$3200.00(-72.2%)
-$14.70 K(-26.5%)
Jun 2019
-
-$11.50 K(<-9900.0%)
-$20.00 K(+10.5%)
Mar 2019
-
$0.00(0.0%)
-$18.10 K(-44.6%)
Dec 2018
-$32.70 K(+230.3%)
$0.00(-100.0%)
-$32.70 K(0.0%)
Sep 2018
-
-$8500.00(-11.5%)
-$32.70 K(+17.6%)
Jun 2018
-
-$9600.00(-34.2%)
-$27.80 K(+28.7%)
Mar 2018
-
-$14.60 K(<-9900.0%)
-$21.60 K(+118.2%)
Dec 2017
-$9900.00(-90.5%)
$0.00(-100.0%)
-$9900.00(-38.1%)
Sep 2017
-
-$3600.00(+5.9%)
-$16.00 K(-82.0%)
Jun 2017
-
-$3400.00(+17.2%)
-$88.70 K(-8.5%)
Mar 2017
-
-$2900.00(-52.5%)
-$96.90 K(-7.4%)
Dec 2016
-$104.60 K(+417.8%)
-$6100.00(-92.0%)
-$104.70 K(+1.9%)
Sep 2016
-
-$76.30 K(+557.8%)
-$102.70 K(+233.4%)
Jun 2016
-
-$11.60 K(+8.4%)
-$30.80 K(+49.5%)
Mar 2016
-
-$10.70 K(+161.0%)
-$20.60 K(+2.0%)
Dec 2015
-$20.20 K
-$4100.00(-6.8%)
-$20.20 K(+25.5%)
Sep 2015
-
-$4400.00(+214.3%)
-$16.10 K(+37.6%)
Jun 2015
-
-$1400.00(-86.4%)
-$11.70 K(+13.6%)
Mar 2015
-
-$10.30 K
-$10.30 K

FAQ

  • What is Axsome Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Axsome Therapeutics?
  • What is Axsome Therapeutics annual CFI year-on-year change?
  • What is Axsome Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Axsome Therapeutics?
  • What is Axsome Therapeutics quarterly CFI year-on-year change?
  • What is Axsome Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Axsome Therapeutics?
  • What is Axsome Therapeutics TTM CFI year-on-year change?

What is Axsome Therapeutics annual cash flow from investing activities?

The current annual CFI of AXSM is -$582.00 K

What is the all time high annual CFI for Axsome Therapeutics?

Axsome Therapeutics all-time high annual cash flow from investing activities is -$9900.00

What is Axsome Therapeutics annual CFI year-on-year change?

Over the past year, AXSM annual cash flow from investing activities has changed by +$53.12 M (+98.92%)

What is Axsome Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of AXSM is -$90.00 K

What is the all time high quarterly CFI for Axsome Therapeutics?

Axsome Therapeutics all-time high quarterly cash flow from investing activities is $0.00

What is Axsome Therapeutics quarterly CFI year-on-year change?

Over the past year, AXSM quarterly cash flow from investing activities has changed by -$83.00 K (-1185.71%)

What is Axsome Therapeutics TTM cash flow from investing activities?

The current TTM CFI of AXSM is -$247.00 K

What is the all time high TTM CFI for Axsome Therapeutics?

Axsome Therapeutics all-time high TTM cash flow from investing activities is -$9900.00

What is Axsome Therapeutics TTM CFI year-on-year change?

Over the past year, AXSM TTM cash flow from investing activities has changed by +$335.00 K (+57.56%)